Research Proposal Review & Collaborations

The two research partners of the ATBC Study project - the U.S. National Cancer Institute (NCI) and the National Institute for Health and Welfare of Finland (THL) - have primary responsibility for project research management, coordination, and oversight. The Metabolic Epidemiology Branch (MEB) represents the NCI in this regard. Study proposals for collaboration are submitted to the NCI or THL Principal Investigators, Dr. Demetrius Albanes and Dr. Satu Männistö, respectively, and are scientifically reviewed at either institution.

A listing of current collaborators appears in Study Investigators and Collaborators. Timeliness, research priority, study design, consideration of unique characteristics of the ATBC Study cohort, and judicious utilization of limited biospecimens are factors relevant to consideration of any proposed research and hypothesis testing.

Approved studies must receive appropriate Institutional Review Board (IRB) review at the collaborating institution. Periodic study progress reports are required and analyses not completed within one year of the originally proposed date may be reassigned.